Finance
Vical announces second-quarter 2002 financial results
Published in TB and Outbreaks Week, September 3rd, 2002
The company reported second quarter 2002 revenues of $2.4 million compared with second quarter 2001 revenues of $1.8 million. Results for the second quarter of 2002 include a $1.0 million payment from Merial for the exercise of additional options under a 1995 agreement for veterinary preventive infectious disease vaccines, and a license payment from Centocor.
The net loss for the second quarter of 2002 was $5.0 million or $0.25 per share, compared with a net loss...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Food-borne Illness
First drug developed for widespread use against botulism - Tuberculosis Therapy
Salicylate agents impair antimicrobial drug efficacy - Infectious Disease Vaccine
VSV-based vaccine may protect against papillomavirus - Polio
UNICEF targets over 1 million Afghan children for immunization - Tuberculosis Therapy
Gender, AIDS status do not affect isoniazid levels - Vaccine Development
Efficacy of tuberculosis vaccine increased by formulation with a cationic colloid - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
